Predictive Models of Psychological Distress, Quality of Life, and Adherence to Medication in Breast Cancer Patients: A Scoping Review

References

• Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer; 2020. Available from: https://gco.iarc.fr/today. Accessed February 24, 2023.
   Google Scholar
• Meier F, Cairo Notari S, Bodenmann G, Revenson TA, Favez N. We are in this together — aren’t we? Congruence of common dyadic coping and psychological distress of couples facing breast cancer. Psychooncology. 2019;28(12):2374–2381. doi:10.1002/pon.5238
   PubMed Web of Science ®Google Scholar
• Nakamura ZM, Deal AM, Nyrop KA, et al. Serial assessment of depression and anxiety by patients and providers in women receiving chemotherapy for early breast cancer. Oncologist. 2021;26(2):147–156. doi:10.1002/onco.13528
   PubMed Web of Science ®Google Scholar
• Ofei SD, Teye-Kwadjo E, Amankwah-Poku M, et al. Determinants of posttraumatic growth and quality of life in Ghanaian breast cancer survivors. Cancer Invest. 2023;2023:1–35.
   Google Scholar
• Zhang J, Zhou Y, Feng Z, Xu Y, Zeng G. Longitudinal trends in anxiety, depression, and quality of life during different intermittent periods of adjuvant breast cancer chemotherapy. Cancer Nurs. 2018;41(1):62–68. doi:10.1097/NCC.0000000000000451
   PubMed Web of Science ®Google Scholar
• Aitken LA, Hossan SZ. The psychological distress and quality of life of breast cancer survivors in Sydney, Australia. Healthc. 2022;10(10):2017. doi:10.3390/healthcare10102017
   Google Scholar
• Maass SWMC, Boerman LM, Verhaak PFM, Du J, de Bock GH, Berendsen AJ. Long-term psychological distress in breast cancer survivors and their matched controls: a cross-sectional study. Maturitas. 2019;130:6–12. doi:10.1016/j.maturitas.2019.09.003
   PubMed Web of Science ®Google Scholar
• Mertz BG, Bistrup PE, Johansen C, et al. Psychological distress among women with newly diagnosed breast cancer. Eur J Oncol Nurs. 2012;16(4):439–443. doi:10.1016/j.ejon.2011.10.001
   PubMed Web of Science ®Google Scholar
• Hashemi SM, Rafiemanesh H, Aghamohammadi T, et al. Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis. Breast Cancer. 2020;27:166–178. doi:10.1007/s12282-019-01031-9
   PubMed Web of Science ®Google Scholar
• Pilevarzadeh M, Amirshahi M, Afsargharehbagh R, Rafiemanesh H, Hashemi SM, Balouchi A. Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis. Breast Cancer Res Treat. 2019;176:519–533. doi:10.1007/s10549-019-05271-3
   PubMed Web of Science ®Google Scholar
• Bhattacharya M, Parsons H, Call K, Blaes A, McAlpine D. Impact of a pre-existing diagnosis of mental illness on stage of breast cancer diagnosis among older women. Breast Cancer Res Treat. 2023;197(1):201–210. doi:10.1007/s10549-022-06793-z
   PubMed Web of Science ®Google Scholar
• Kanani R, Davies EA, Hanchett N, Jack RH. The association of mood disorders with breast cancer survival: an investigation of linked cancer registration and hospital admission data for South East England. Psychooncology. 2016;25(1):19–27. doi:10.1002/pon.4037
   PubMed Web of Science ®Google Scholar
• Syrowatka A, Hanley JA, Weir DL, Dixon WG, Meguerditchian AN, Tamblyn R. Ability to predict new-onset psychological distress using routinely collected health data: a population-based cohort study of women diagnosed with breast cancer. JNCCN J Natl Compr Cancer Netw. 2018;16(9):1065–1073. doi:10.6004/jnccn.2018.7038
   PubMed Web of Science ®Google Scholar
• Wang X, Wang N, Zhong L, et al. Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients. Mol Psychiatry. 2020;25:3186–3197. doi:10.1038/s41380-020-00865-6
   PubMed Web of Science ®Google Scholar
• Ayalew TL, Wale BG, Haile KE, Zewudie BT, Feleke MG. Health-related quality of life and associated factors among cancer patients in Ethiopia: systematic review and meta-analysis. PLoS One. 2022;17:1.
   Google Scholar
• Mokhtari-Hessari P, Montazeri A. Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018. Health Qual Life Outcomes. 2020;18:1–25. doi:10.1186/s12955-020-01591-x
   PubMedGoogle Scholar
• Javan Biparva A, Raoofi S, Rafiei S, et al. Global quality of life in breast cancer: systematic review and meta-analysis. BMJ Support Palliat Care. 2022;1:1–9.
   Google Scholar
• Jiang H, Dong Y, Zong W, Zhang X, Xu H, Jin F. The relationship among psychosocial adaptation, medication adherence and quality of life in breast cancer women with adjuvant endocrine therapy. BMC Women's Health. 2022;22(1). doi:10.1186/s12905-022-01722-0
   Web of Science ®Google Scholar
• Yussof I, Mohd Tahir NA, Hatah E, Mohamed Shah N. Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: a systematic review. Breast. 2022;62:22–35. doi:10.1016/j.breast.2022.01.012
   PubMed Web of Science ®Google Scholar
• Pinheiro LC, Wheeler SB, Reeder-Hayes KE, Samuel CA, Olshan AF, Reeve BB. Investigating associations between health-related quality of life and endocrine therapy underuse in women with early-stage breast cancer. J Oncol Pract. 2017;13(5):e463–71. doi:10.1200/JOP.2016.018630
   PubMed Web of Science ®Google Scholar
• Inotai A, Ágh T, Maris R, et al. Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer. Cancer Treat Rev. 2021;100:102264. doi:10.1016/j.ctrv.2021.102264
   PubMed Web of Science ®Google Scholar
• Stahlschmidt R, Ferracini AC, de Souza CM, de Medeiros LM, Juliato CRT, Mazzola PG. Adherence and quality of life in women with breast cancer being treated with oral hormone therapy. Support Care Cancer. 2019;27(10):3799–3804. doi:10.1007/s00520-019-04671-x
   PubMed Web of Science ®Google Scholar
• Bai X, Zhang X, Xiang W, et al. Time tracking and multidimensional influencing factors analysis on female breast cancer mortality: evidence from urban and rural China between 1994 to 2019. Front Public Heal. 2022;2022:10.
   Google Scholar
• Coughlin SS. Social determinants of breast cancer risk, stage, and survival. Breast Cancer Res Treat. 2019;177:537–548. doi:10.1007/s10549-019-05340-7
   PubMed Web of Science ®Google Scholar
• Emerson MA, Reeve BB, Gilkey MB, et al. Job loss, return to work, and multidimensional well-being after breast cancer treatment in working-age Black and White women. J Cancer Surviv. 2022;17:805–814. doi:10.1007/s11764-022-01252-6
   PubMed Web of Science ®Google Scholar
• Veličković K, Borrebaeck CAK, Bendahl PO, et al. One-year recovery from breast cancer: importance of tumor and treatment-related factors, resilience, and sociodemographic factors for health-related quality of life. Front Oncol. 2022;12. doi:10.3389/fonc.2022.891850
   PubMed Web of Science ®Google Scholar
• Achimaș-Cadariu P, Iancu M, Pop F, Vlad C, Irimie A. Psychological screening and health related quality of life in Romanian breast cancer survivors. J Evid Based Psychother. 2015;15(2):267.
   Web of Science ®Google Scholar
• Di Meglio A, Havas J, Soldato D, et al. Development and validation of a predictive model of severe fatigue after breast cancer diagnosis: toward a personalized framework in survivorship care. J Clin Oncol. 2022;40(10):1111–1123. doi:10.1200/JCO.21.01252
   PubMed Web of Science ®Google Scholar
• Giedzinska AS, Meyerowitz BE, Ganz PA, Rowland JH. Health-related quality of life in a multiethnic sample of breast cancer survivors. Ann Behav Med. 2004;28(1):39–51. doi:10.1207/s15324796abm2801_6
   PubMed Web of Science ®Google Scholar
• Schnoll RA, Knowles JC, Harlow L. Correlates of adjustment among cancer survivors. J Psychosoc Oncol. 2002;20(1):37–59. doi:10.1300/J077v20n01_03
   Web of Science ®Google Scholar
• Seow H, Tanuseputro P, Barbera L, et al. Development and validation of a prediction model of poor performance status and severe symptoms over time in cancer patients (PROVIEW+). Palliat Med. 2021;35(9):1713–1723. doi:10.1177/02692163211019302
   PubMed Web of Science ®Google Scholar
• Aquil A, El Kherchi O, El Azmaoui N, et al. Predictors of mental health disorders in women with breast and gynecological cancer after radical surgery: a cross-sectional study. Ann Med Surg. 2021;65:102278. doi:10.1016/j.amsu.2021.102278
   PubMed Web of Science ®Google Scholar
• Gõmez-Campelo P, Bragado-álvarez C, Hernández-Lloreda MJ. Psychological distress in women with breast and gynecological cancer treated with radical surgery. Psychooncology. 2014;23(4):459–466. doi:10.1002/pon.3439
   PubMed Web of Science ®Google Scholar
• Kourou K, Manikis G, Poikonen-Saksela P, et al. A machine learning-based pipeline for modeling medical, socio-demographic, lifestyle and self-reported psychological traits as predictors of mental health outcomes after breast cancer diagnosis: an initial effort to define resilience effects. Comput Biol Med. 2021;131:104266. doi:10.1016/j.compbiomed.2021.104266
   PubMed Web of Science ®Google Scholar
• Lopes C, Severo M, Fontes F, et al. Trajectories of anxiety and depression symptoms over five years since breast cancer diagnosis: results of the NEON-BC prospective study. Healthc. 2022;10(4):661. doi:10.3390/healthcare10040661
   Google Scholar
• Munn Z, Peters MDJ, Stern C, et al. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18:143. doi:10.1186/s12874-018-0611-x
   PubMed Web of Science ®Google Scholar
• Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–473. doi:10.7326/M18-0850
   PubMed Web of Science ®Google Scholar
• Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA. Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol. 2003;21(21):4027–4033. doi:10.1200/JCO.2003.08.097
   PubMed Web of Science ®Google Scholar
• Haun MW, Simon L, Sklenarova H, Zimmermann-Schlegel V, Friederich H-C, Hartmann M. Predicting anxiety in cancer survivors presenting to primary care - A machine learning approach accounting for physical comorbidity. Cancer Med. 2021;10(14):5001–5016. doi:10.1002/cam4.4048
   PubMed Web of Science ®Google Scholar
• Hong SJ, Shin NM, Jung S. A predictive model of fear of cancer recurrence for patients undergoing chemotherapy. Support Care Cancer. 2020;28:4173–4181. doi:10.1007/s00520-019-05245-7
   PubMed Web of Science ®Google Scholar
• Morasso G, Costantini M, Viterbori P, et al. Predicting mood disorders in breast cancer patients. Eur J Cancer. 2001;37(2):216–223. doi:10.1016/S0959-8049(00)00390-7
   PubMed Web of Science ®Google Scholar
• Liang MZ, Tan Y, Knobf MT, et al. Resilience index improves prediction of 1-year decreased quality of life in breast cancer. J Cancer Surviv. 2022;2022:1–10.
   Google Scholar
• Ashing-Giwa KT, Tejero JS, Kim J, Padilla GV, Hellemann G. Examining predictive models of HRQOL in a population-based, multiethnic sample of women with breast carcinoma. Qual Life Res. 2007;16:413–428. doi:10.1007/s11136-006-9138-4
   PubMed Web of Science ®Google Scholar
• Carmona-Bayonas A, Calderón C, Hernández R, et al. Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy. NPJ Breast Cancer. 2021;7(1):92. doi:10.1038/s41523-021-00296-8
   PubMed Web of Science ®Google Scholar
• Cahir C, Barron TI, Sharp L, Bennett K. Can demographic, clinical and treatment-related factors available at hormonal therapy initiation predict non-persistence in women with stage I–III breast cancer? Cancer Causes Control. 2017;28:215–225. doi:10.1007/s10552-017-0851-9
   PubMed Web of Science ®Google Scholar
• Henry NL, Azzouz F, Desta Z, et al. Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. J Clin Oncol. 2012;30(9):936. doi:10.1200/JCO.2011.38.0261
   PubMed Web of Science ®Google Scholar
• Kuo CC, Wang HH, Tseng LP. Using data mining technology to predict medication‐taking behaviour in women with breast cancer: a retrospective study. Nursing Open. 2022;9(6):2646–2656. doi:10.1002/nop2.963
   PubMed Web of Science ®Google Scholar
• Meneveau MO, Keim-Malpass J, Camacho TF, Anderson RT, Showalter SL. Predicting adjuvant endocrine therapy initiation and adherence among older women with early-stage breast cancer. Breast Cancer Res Treat. 2020;184:805–816. doi:10.1007/s10549-020-05908-8
   PubMed Web of Science ®Google Scholar
• Shinn E, Busch BE, Jasemi N, et al. Network modeling of complex time-dependent changes in patient adherence to adjuvant endocrine treatment in ER+ breast cancer. Frontiers in Psychology. 2022;2022:4172.
   Google Scholar
• Yanez B, Gray RJ, Sparano JA, et al. Association of modifiable risk factors with early discontinuation of adjuvant endocrine therapy: a post hoc analysis of a randomized clinical trial. JAMA Oncol. 2021;7(8):1196–1202. doi:10.1001/jamaoncol.2021.1693
   Web of Science ®Google Scholar
• Spitzer RL, Williams JBW, Gibbon M, First MB. The structured clinical interview for DSM-III-R (SCID): i: history, rationale, and description. Arch Gen Psychiatry. 1992;49(8):624–629. doi:10.1001/archpsyc.1992.01820080032005
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x
   PubMed Web of Science ®Google Scholar
• Hopwood P, Fletcher I, Lee A, Al Ghazal S. A body image scale for use with cancer patients. Eur J Cancer. 2001;37(2):189–197. doi:10.1016/S0959-8049(00)00353-1
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8(1):77–100. doi:10.1016/0272-7358(88)90050-5
   Web of Science ®Google Scholar
• Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893–897. doi:10.1037/0022-006X.56.6.893
   PubMed Web of Science ®Google Scholar
• Greer JA, Amoyal N, Nisotel L, et al. A systematic review of adherence to oral antineoplastic therapies. Oncologist. 2016;21(3):354–376. doi:10.1634/theoncologist.2015-0405
   PubMed Web of Science ®Google Scholar
• Hwang KS, Lee KH, Yang CM, Lee HJ, Lee SY. Effects of psychosocial interventions for patients with breast cancer: a meta-analysis. Clin Psychopharmacol Neurosci. 2023;21(1):118–125. doi:10.9758/cpn.2023.21.1.118
   PubMed Web of Science ®Google Scholar
• Lai J, Song H, Ren Y, Li S, Xiao F. Effectiveness of supportive-expressive group therapy in women with breast cancer: a systematic review and meta-analysis. Oncol Res Treat. 2021;44:252–260. doi:10.1159/000515756
   PubMed Web of Science ®Google Scholar
• Wong WM, Chan DNS, He X, So WKW. Effectiveness of pharmacological and nonpharmacological interventions for managing the fatigue–sleep disturbance–depression symptom cluster in breast cancer patients undergoing chemotherapy. Cancer Nurs. 2022;46:E70–E80. doi:10.1097/NCC.0000000000001048
   PubMed Web of Science ®Google Scholar
• Johannsen M, Farver I, Beck N, Zachariae R. The efficacy of psychosocial intervention for pain in breast cancer patients and survivors: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;138(3):675–690. doi:10.1007/s10549-013-2503-4
   PubMed Web of Science ®Google Scholar
• Abrahams HJG, Knoop H, Schreurs M, et al. Moderators of the effect of psychosocial interventions on fatigue in women with breast cancer and men with prostate cancer: individual patient data meta-analyses. Psychooncology. 2020;29:1772–1785. doi:10.1002/pon.5522
   PubMed Web of Science ®Google Scholar
• Ream ME, Walsh EA, Jacobs JM, et al. Brief relaxation training is associated with long-term endocrine therapy adherence among women with breast cancer: post hoc analysis of a randomized controlled trial. Breast Cancer Res Treat. 2021;190(1):79–88. doi:10.1007/s10549-021-06361-x
   PubMed Web of Science ®Google Scholar
• Arch JJ, Crespi CM, Levin ME, et al. Randomized controlled pilot trial of a low-touch remotely-delivered values intervention to promote adherence to adjuvant endocrine therapy among breast cancer survivors. Ann Behav Med. 2022;56(8):856–871. doi:10.1093/abm/kaab118
   PubMed Web of Science ®Google Scholar
• Mustafa M, Carson-Stevens A, Gillespie D, Edwards AGK. Psychological interventions for women with metastatic breast cancer. Cochrane Database Syst Rev. 2013;2013:1.
   Google Scholar
• Andersen BL, Yang HC, Farrar WB, et al. Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer. 2008;113(12):3450–3458. doi:10.1002/cncr.23969
   PubMed Web of Science ®Google Scholar
• Elting LS, Shih YCT. The economic burden of supportive care of cancer patients. Support Care Cancer. 2004;12:219–226. doi:10.1007/s00520-003-0513-1
   PubMed Web of Science ®Google Scholar
• Varga TV, Niss K, Estampador AC, Collin CB, Moseley PL. Association is not prediction: a landscape of confused reporting in diabetes – a systematic review. Diabetes Res Clin Pract. 2020;170:108497. doi:10.1016/j.diabres.2020.108497
   PubMed Web of Science ®Google Scholar